|

How to vet a peptide supplier: a checklist for research labs

The research-peptide market is unregulated, inconsistently documented, and full of operators whose catalogs are indistinguishable from the catalogs of competent manufacturers. A lab that buys on price alone, or on web-design alone, will at some point buy a vial that is not what the label says.

This is a concrete checklist. Every item is a question you can ask, a document you can request, or a verification you can perform before placing an order. If a supplier cannot answer most of these, you have your answer about the supplier.

Documentation you should receive without asking

  • A lot-specific COA. Not a generic product-level datasheet, a document that identifies the specific lot number on the vial and reports measured values, not aspirations.
  • HPLC chromatogram. The actual chromatogram, not a summary statistic. Peaks, retention times, baseline.
  • Mass-spec identity spectrum. The measured mass, with isotope pattern, matched to theoretical.
  • Signed release. Named QC chemist and QA approver, with date of release.
  • Storage and handling sheet. Recommended temperature, reconstitution guidance, stability data.

See How to read a peptide COA for a field guide to each line item.

Ten questions to ask before the first order

QuestionWhat a good answer looks like
Where is the peptide synthesized?A named manufacturing partner and a specific facility location.
Who performs the release testing?Either the manufacturer with independent audit, or a third-party lab by name. Not "our internal QC" with no further detail.
What reference standard do you use for HPLC identity?A named commercial or in-house reference with a traceable COA of its own.
What is the limit of detection for impurity peaks?A specific LOD, typically 0.1% or lower. "Impurities below detection" without a threshold is meaningless.
What is your policy on lot segregation?New lot = new COA. No blending of lots to fill orders.
What is the retest policy?A defined retest interval and a documented re-release procedure.
Do you carry product liability insurance?Yes, with a named carrier and a coverage limit, not a hand-wave.
How do you handle out-of-spec results?A documented OOS procedure with investigation, root-cause analysis, and disposition (release, reject, rework).
Can I audit?Yes, with advance scheduling. A supplier that refuses site visits is a supplier that has something to hide.
What is your chain of custody after synthesis?Sealed, tracked, refrigerated where indicated. A specific answer with handoff points named.

Three verifications you can perform yourself

1. Cross-check the COA against a third-party lab

For any new supplier, send a sample of your first lot to an independent analytical lab (Alera, Intertek, Eurofins Covance all run peptide HPLC + MS). Compare the independent result to the supplier’s COA. Minor variance is normal (±0.3% HPLC purity between labs); a discrepancy greater than 2% suggests either a documentation error or a substituted material.

2. Check the physical vial

  • Lot number on the vial matches the lot number on the COA.
  • Fill weight, if stated, matches your own gravimetric check after equilibration.
  • Powder is fluffy and free-flowing for a properly lyophilized peptide. Cake is acceptable; liquid residue is not.
  • Closure is intact, septum is unpunctured, tamper seal is present.

3. Look up the supplier

  • Business registration in the jurisdiction they claim to operate from.
  • Physical address that is not a residential address or a mail-drop.
  • Named company officers, at minimum a CEO or technical lead, who exist on LinkedIn or in a regulatory filing.
  • Any published work, third-party reviews in research-community forums, or citations in primary literature.

A supplier that will not tell you where their peptide is made, who tests it, or who signs the COA is not a supplier. It is a shipping address.

Red flags that should end the conversation

  • No lot-specific COA.
  • COA with no chromatogram, or with a chromatogram that appears in every lot’s COA unchanged.
  • Identical “as measured” values across many lots, real measurements have natural variance.
  • Claims of pharmaceutical-grade or GMP-compliant production without certification.
  • Prices substantially below the market floor for the compound class.
  • Refusal or inability to answer any of the ten questions above.
  • Marketing copy that describes the peptide’s effects in humans (a research-grade supplier does not market to end users).

See seven COA red flags for document-level diagnostics.

What a credible supplier should provide by default

Against the checklist above, a credible supplier should provide: lot-specific COA with full chromatogram, ESI-MS identity confirmation, RP-HPLC purity against a documented acceptance criterion, signed release, full synthesis provenance, and a named QC chemist of record. Every lot. Without being asked. Where we stand: our Freedom Diagnostics reports show the chromatogram, mass-spec identity and purity. Our older supplier-ordered Janoshik reports do not. None of our reports includes a signed release or a named QC chemist. The public lot ledger shows which report each lot has.

Related reading

Research use only. The guidance here is for evaluating suppliers of research-grade material. Clarion peptides are not drugs and are not supplied for human or veterinary use.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *